China NMPA Product Recall - Biochemical general quality control products

On August 11, 2017, Ausendo Medical Devices Trading (China) Co., Ltd. announced a voluntary Class III recall of its general biochemical quality control products, identified by Registration No.: 20172400282. This significant action, overseen by the National Medical Products Administration (NMPA), was prompted by a critical quality non-conformance. Specifically, unopened products from batch K4852 were found to fail the specified quality requirement for refrigerated storage, which mandates stability for up to six months as detailed in the product instructions. The company's proactive recall underscores the importance of maintaining stringent quality standards for medical devices, particularly those used in sensitive biochemical applications where accurate and reliable control products are essential for valid test results. A failure in storage stability could potentially impact the efficacy and safety of diagnostic procedures where these quality controls are employed. Ausendo Medical Devices Trading (China) Co., Ltd. reported the issue, highlighting their commitment to product integrity. The Level III classification indicates that while the issue might not pose an immediate severe health risk, it warrants immediate correction to prevent potential adverse outcomes associated with compromised product performance. Further detailed information regarding specific models, specifications, and batch identifiers for the affected products is provided in the accompanying "Medical Event Report Form." This recall ensures the removal of potentially substandard products from the market, upholding public health standards.